Drugs / carcinoembryonic antigen RNA-pulsed DC cancer vaccine
carcinoembryonic antigen RNA-pulsed DC cancer vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00003433 | Jun 1998 → Aug 2003 | colorectal cancer, metastatic malignant neoplasm | Duke Cancer Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | carcinoembryonic antigen RNA-pulsed DC cancer vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003433 ↗ |
| Modality | Cell therapy | “Autologous, cultured dendritic cells” NCT00003433 ↗ |
| Route | Intravenous | “Patients receive CEA RNA pulsed dendritic cells intravenously” NCT00003433 ↗ |